Location History:
- Mokpo Jeonnam KR (2008)
- Daejeon, KR (2021)
Company Filing History:
1 out of 2 
1 out of 832,843 Years Active: 2008-2021
Title: Gun Sik Cho: Innovator in Tissue Fibrosis Treatment and Blood Pressure Management
Introduction
Gun Sik Cho is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biomedical innovations, particularly in the treatment of tissue fibrosis and blood pressure management. With a total of 2 patents, his work showcases the potential for improving health outcomes through innovative solutions.
Latest Patents
Gun Sik Cho's latest patents include a recombinant protein for preventing or treating tissue fibrosis and a method for producing a chitosan-containing salt that lowers blood pressure. The recombinant protein is based on milk fat globule-EGF factor 8 (MFG-E8) and comprises the amino acid sequence of SEQ ID NO: 1. This invention significantly enhances the effectiveness of preventing or treating tissue fibrosis compared to conventional methods. The second patent details a method for producing a chitosan-containing salt, which involves binding chitosan to salt particles without the need for recrystallization, thereby reducing production costs.
Career Highlights
Throughout his career, Gun Sik Cho has worked with various companies, including Nexel Co., Ltd. His innovative approaches have positioned him as a key figure in the development of new therapeutic methods.
Collaborations
Gun Sik Cho has collaborated with notable colleagues such as Choong Seong Han and Dong Hun Woo. Their combined expertise has contributed to the advancement of his research and inventions.
Conclusion
Gun Sik Cho's work exemplifies the impact of innovation in healthcare, particularly in addressing critical issues like tissue fibrosis and hypertension. His patents reflect a commitment to improving patient outcomes through scientific advancements.